Author: Dr. Clemens

Uncategorized Published - 10 July, 2014    By - Dr. Clemens
Effective low dosage of mepivacaine in ultrasound-guided axillary nerve block: a double-blinded, randomized clinical trial of efficacy in patients undergoing distal upper extremity surgery

Published in J Clin Anesth. 2014 May;26(3):222-6 Authors: Perov S et al STUDY OBJECTIVE: To evaluate two low-dose volumes (20 mL or 30 mL) of 1.5% mepivacaine solution used for ultrasound-guided axillary blockade for outpatients undergoing distal upper limb surgery. DESIGN: Prospective, double-blinded randomized study. SETTING: Outpatient surgical setting of a university-affiliated hospital. PATIENTS: 64 […]

Read More
Uncategorized Published - 10 July, 2014    By - Dr. Clemens
Time to administration of epinephrine and outcome after in-hospital cardiac arrest with non-shockable rhythms: retrospective analysis of large in-hospital data registry

Published in BMJ. 2014 May 20;348:g3028 Authors: Donnino MW et OBJECTIVE: To determine if earlier administration of epinephrine (adrenaline) in patients with non-shockable cardiac arrest rhythms is associated with increased return of spontaneous circulation, survival, and neurologically intact survival. DESIGN: Post hoc analysis of prospectively collected data in a large multicenter registry of in-hospital cardiac […]

Read More
Uncategorized Published - 10 July, 2014    By - Dr. Clemens
The influence of glucose load on metabolism during minor surgery using remifentanil-induced anesthesia

Published in Acta Anaesthesiol Scand. 2014 Apr 29 Authors: Kambe N et al BACKGROUND: During perioperative fasting, lipid metabolism gradually increases, resulting in free fatty acids (FFA) and/or ketone bodies. Suppression of surgical stress by remifentanil may allow the safe administration of glucose infusions, avoiding both hyperglycemia and ketogenesis. The effects of glucose infusion on […]

Read More
Uncategorized Published - 10 July, 2014    By - Dr. Clemens
Senate Confirms Sylvia Burwell as New HHS Chief

The Senate today confirmed Sylvia Mathews Burwell as the next secretary of the US Department of Health and Human Services (HHS) in a 78 to 17 vote that shows how her job of implementing the Affordable Care Act (ACA) will not be easy. Although the vote was overwhelmingly in Burwell’s favor, she had received unanimous […]

Read More
Uncategorized Published - 24 June, 2014    By - Dr. Clemens
Anesthesia Management: Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis

Published in Allergy. 2014 Jul;69(7):954-9 Authors: Reitter M et al BACKGROUND: Anaphylactic reactions to neuromuscular blocking agents (NMBAs) can be severe and even fatal. Our aim was to evaluate mortality rate in France from anaphylactic reactions to NMBAs, to identify risk factors for a fatal outcome, and to describe management of the cases that proved […]

Read More
Uncategorized Published - 24 June, 2014    By - Dr. Clemens
Anesthesia Management: Novel Technique Confirms Femoral Line Placement Using Cardiac Ultrasound

Authors: Horowitz R et al., Ann Emerg Med 2014 Jan 17; Injecting agitated saline into a femoral venous line while sonographically imaging the heart confirms the line’s location. Accidental placement of a femoral venous catheter into the artery can cause limb ischemia, especially in children, who have small femoral arteries. Investigators assessed ability of the […]

Read More
Uncategorized Published - 24 June, 2014    By - Dr. Clemens
Anesthesia Management: Medicare Payments for E/M Services: 10 Things to Know

The HHS Office of Inspector General released a report finding Medicare inappropriately paid $6.7 billion for evaluation and management services claims in 2010. Here are 10 key things to know about E/M services, their coding and documentation requirements, and the improper Medicare payments. 1. E/M services are covered under Medicare Part B and are performed […]

Read More
Uncategorized Published - 22 June, 2014    By - Dr. Clemens
Anesthesia Management: Chronic Migraine Responds to OnabotulinumtoxinA

OnabotulinumtoxinA (Botox, Allergan Inc) continues to relieve migraine headache when given over the long term, according to a retrospective analysis of patients with chronic migraine treated for 9 treatment cycles, 12 weeks apart. “Doctors can now tell their patients that Botox is a safe and effective treatment for chronic migraine, with data now reported over […]

Read More
Uncategorized Published - 22 June, 2014    By - Dr. Clemens
Anesthesia Management: Oxycodone/Naloxone an ADF Option for Chronic Low Back Pain

A novel extended-release formulation of oxycodone and naloxone in a fixed 2:1 ratio (OXN, Purdue Pharma) may be useful as an abuse-deterrent formulation (ADF) option in the treatment of opioid-experienced patients with chronic low back pain. “Chronic low back pain is a huge public health problem,” Jerry A. Green, MD, from Purdue Pharma, LP, Stamford, […]

Read More
Uncategorized Published - 22 June, 2014    By - Dr. Clemens
Anesthesia Management: Getting Hooked on Pain Meds Postoperatively

Authors: Clarke H et al., BMJ 2014 Feb 11; 348:g1251 A small but substantial percentage of opiate-naïve patients were still taking pain medications 90 days after major surgery. Annually, more than 200 million patients undergo major surgery worldwide. Many patients require treatment with opiates for moderate-to-severe postoperative pain; most quickly transition off of pain medications. […]

Read More